presents

ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing RegimenACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen

ACTG Presents Study at CROI Demonstrating Increased Risk of Obesity and Cardiometabolic Disease After Switch to Integrase Inhibitor-Containing Regimen

LOS ANGELES, March 08, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious…

2 months ago
Parimatch Presents: Exclusive Interview with Mystery Bowler Sunil NarineParimatch Presents: Exclusive Interview with Mystery Bowler Sunil Narine

Parimatch Presents: Exclusive Interview with Mystery Bowler Sunil Narine

MUMBAI, India, March 7, 2025 /PRNewswire/ -- As the Indian T20 League approaches, cricket fever is reaching new heights, and…

2 months ago
Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025

Celldex Therapeutics Presents Positive Results from Barzolvolimab Phase 2 Studies in Patients with Chronic Urticaria Demonstrating Improved Disease Control and Quality of Life at AAAAI 2025

March 01, 2025 12:45 ET  | Source: Celldex Therapeutics, Inc. - Greatly improved patient quality of life and reduced disease…

2 months ago
Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual MeetingJasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

Jasper Therapeutics Presents Clinical and Preclinical Briquilimab Data at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual Meeting

REDWOOD CITY, Calif., March 01, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company…

2 months ago
EverCommerce Presents at the Citizens JMP Tech ConferenceEverCommerce Presents at the Citizens JMP Tech Conference

EverCommerce Presents at the Citizens JMP Tech Conference

February 28, 2025 13:29 ET  | Source: EverCommerce Inc. DENVER, Feb. 28, 2025 (GLOBE NEWSWIRE) -- EverCommerce Inc. (NASDAQ: EVCM),…

2 months ago
ECR 2025: Esaote Group presents Integrated Medical Imaging Solutions and unveils innovations in Ultrasound TechnologyECR 2025: Esaote Group presents Integrated Medical Imaging Solutions and unveils innovations in Ultrasound Technology

ECR 2025: Esaote Group presents Integrated Medical Imaging Solutions and unveils innovations in Ultrasound Technology

Ebit showcases SUITESTENSA ZEfiRO: the new "cloud-native" PACS with diagnostic viewer VIENNA, Feb. 26, 2025 /PRNewswire/ -- Esaote Group, a leading…

2 months ago
JULIEN’S AUCTIONS PRESENTS BOLD LUXURY: THE LIMELIGHT EDITJULIEN’S AUCTIONS PRESENTS BOLD LUXURY: THE LIMELIGHT EDIT

JULIEN’S AUCTIONS PRESENTS BOLD LUXURY: THE LIMELIGHT EDIT

Featuring Iconic Fashion from Marilyn Monroe, Elizabeth Taylor, Cher, Victoria Beckham, Amy Winehouse, Hermes, Chanel, Giambatista Valli & More A…

2 months ago
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program

February 08, 2025 14:30 ET  | Source: 4D Molecular Therapeutics, Inc. 3E10 vg/eye achieved an 83% reduction in injection burden…

2 months ago
Bybit Card Presents Valentine’s Special: 14% Cashback for 24 Hours OnlyBybit Card Presents Valentine’s Special: 14% Cashback for 24 Hours Only

Bybit Card Presents Valentine’s Special: 14% Cashback for 24 Hours Only

DUBAI, UAE, Feb. 7, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is pleased to announce…

3 months ago
Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke ConferenceRecursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference

Recursion Presents Phase 2 Data for REC-994 in CCM in Late-Breaking Oral Presentation at the International Stroke Conference

Met primary endpoint of safety and tolerability in CCM patients with no treatment-related discontinuations or Grade 3 adverse eventsIn comparison…

3 months ago